In-silico analysis of novel p.(Gly14Ser) variant of ATOX1 gene: plausible role in modulating ATOX1–ATP7B interaction
- 58 Downloads
Clinical heterogeneity is commonly observed in Wilson disease (WD), including cases with identical ATP7B mutations. It is thought to be an outcome of impairment in other genes involved in cellular copper homeostasis in addition to the mutations in the ATP7B gene. ATOX1, a copper chaperone that delivers copper to ATP7B, is a potential genetic modifier of WD. In the present study, we analyzed the genetic variations in the ATOX1 gene in 50 WD patients and 60 controls. We identified four novel variants, of which, the coding region variant c.40G > A, p.(Gly14Ser) was observed in 2% alleles. Interestingly, p.(Gly14Ser) was seen with an early onset age, reduced serum ceruloplasmin level and manifestations of liver and brain in a WD patient unlike the other having identical ATP7B mutation but normal ATOX1 alleles. Further, computational analysis predicted that p.(Gly14Ser) substitution, in the critical copper binding motif (MXCXG14C) of the protein, affects the protein–protein interaction involved in copper sharing and transfer between ATOX1 and ATP7B-MBD4. Our findings suggest that p.(Gly14Ser) variant of ATOX1 might play a role as a genetic modifier leading to phenotypic variation in WD.
KeywordsATOX1 ATP7B Cu chaperone Modifier Phenotype Wilson disease
We thank the patients and families for their kind participation and interest in this study. The work was supported by grants from the Indian Council of Medical Research, New Delhi, India (Grant Nos. 54/1/2014-BMS and 3/1/3/JRF-2012/HRD-53).
Compliance with ethical standards
Conflict of interest
The authors declare no conflicts of interest.
- 4.Okada T, Shiono Y, Hayashi H, Satoh H, Sawada T, Suzuki A et al (2000) Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson’s disease. Hum Mutat 15:454–462. https://doi.org/10.1002/(SICI)1098-1004(200005)15:5%3c454:AID-HUMU7%3e3.0.CO;2-J CrossRefGoogle Scholar
- 5.Chang IJ, Hahn SH (2017) The genetics of Wilson disease. Handb Clin Neurol 142:19–34. https://doi.org/10.1016/B978-0-444-63625-6.00003-3 CrossRefGoogle Scholar
- 6.Medici V, Weiss KH (2017) Genetic and environmental modifiers of Wilson disease. Handb Clin Neurol 142:35–41. https://doi.org/10.1016/B978-0-444-63625-6.00004-5 CrossRefGoogle Scholar
- 23.Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Gallo Cassarino T, Bertoni M, Bordoli L, Schwede T (2014) SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42:W252–W258. https://doi.org/10.1093/nar/gku340 CrossRefGoogle Scholar